Diabetes and Atherosclerosis

Сахарный диабет и атеросклероз
Peter Libby, Mark A. Creager, Joshua A. Beckman
2002-05-15

Antiplatelet drugsAtherosclerosisCardiovascular eventsDiabetes mellitusLipid-lowering therapy
CONTEXT: Complications of atherosclerosis cause most morbidity and mortality in patients with diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy remains incompletely understood and underused. OBJECTIVE: To review the epidemiology, pathophysiology, and medical and invasive treatment of atherosclerosis in patients with diabetes mellitus. DATA SOURCES: Using the index terms diabetes mellitus, myocardial infarction, peripheral vascular diseases, cerebrovascular accident, endothelium, vascular smooth muscle, platelets, thrombosis, cholesterol, hypertension, hyperglycemia, insulin, angioplasty, and coronary artery bypass, we searched the MEDLINE and EMBASE databases from 1976 to 2001. Additional data sources included bibliographies of identified articles and preliminary data presented at recent cardiology conferences. STUDY SELECTION: We selected original investigations and reviews of the epidemiology, pathophysiology, and therapy of atherosclerosis in diabetes. We selected randomized, double-blind, controlled studies, when available, to support therapeutic recommendations. Criteria for data inclusion (168 of 396) included publication in a peer-reviewed journal or presentation at a national cardiovascular society-sponsored meeting. DATA EXTRACTION: Data quality was determined by publication in peer-reviewed literature. Data extraction was performed by one of the authors. DATA SYNTHESIS: Diabetes mellitus markedly increases the risk of myocardial infarction, stroke, amputation, and death. The metabolic abnormalities caused by diabetes induce vascular dysfunction that predisposes this patient population to atherosclerosis. Blood pressure control, lipid-lowering therapy, angiotensin-converting enzyme inhibition, and antiplatelet drugs significantly reduce the risk of cardiovascular events. Although diabetic patients undergo revascularization procedures because of acute coronary syndromes or critical limb ischemia, the outcomes are less favorable than in nondiabetic cohorts. CONCLUSIONS: Since most patients with diabetes die from complications of atherosclerosis, they should receive intensive preventive interventions proven to reduce their cardiovascular risk.
1
Atherosclerotic complications cause most morbidity and mortality among patients with diabetes, yet proven medical therapies remain incompletely understood and underused.
2
Blood pressure control, lipid-lowering therapy, angiotensin-converting enzyme inhibition, and antiplatelet treatment significantly reduce cardiovascular event risk.
3
Diabetes mellitus markedly increases the risks of myocardial infarction, stroke, amputation, and death from atherosclerotic complications.
4
Diabetes-related metabolic abnormalities induce vascular dysfunction that predisposes patients to atherosclerosis.
5
Patients with diabetes undergo revascularization for acute coronary syndromes or critical limb ischemia, although outcomes are described as less favorable.

Atherosclerosis in patients with diabetes mellitus

The epidemiology, pathophysiology, and medical and invasive treatment of atherosclerosis, including cardiovascular risk and outcomes, in diabetes mellitus

Publication Details
Publication Date
2002-05-15
Journal
Publisher
ISSN
Cited by
2774
Access Type
Author Information
Authors
Peter Libby
Mark A. Creager
Joshua A. Beckman
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%